#vivo

Collection of vivo news, found 45 news.

MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche

 MediLink Therapeutics ("MediLink"), announced today that it has entered into a worldwide collaboration and ...

China-ASEAN media tour explores Indonesian heritage

A delegation from China visited Indonesia from November 21 to 23 to conduct a media tour themed "Song of Our ...

BRIN develops oral vaccine for hepatitis

The National Research and Innovation Agency (BRIN) formulates and develops an oral vaccine utilizing a combination of ...

Unair initiates first hemodialysis membrane production in Indonesia

Airlangga University (Unair) in Surabaya has initiated the first production of hemodialysis membranes in Indonesia as ...

Celmatix announces achievement of key preclinical milestones in premature menopause prevention drug program

Celmatix Inc. a biotechnology company focused on ovarian biology, today announced the identification of a novel AMHR2 ...

Supporting COVID vaccine seed preparation for pre-clinical trial

The Eijkman Institute for Molecular Biology (PRBME) is following up on and supporting the development and preparation ...

BRIN builds research facility for traditional food processing

The National Research and Innovation Agency (BRIN) has built a research facility for traditional food processing that ...

Development of indigenous COVID-19 vaccine big challenge: BRIN

Developing the Merah Putih COVID-19 vaccine is a big challenge as no single country has experience in developing such a ...

Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant

Celltrion Group announced today results for its cocktail therapy candidates including neutralisation data against the ...

Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19

Celltrion Group announced today that the European Commission (EC) has approved Regkirona (regdanvimab, CT-P59), one of ...

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

Celltrion Group announced today that the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for ...

Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a ...

Telkomsel expands VoLTE services to strengthen 5G ecosystem

State-owned mobile operator Telkomsel continues to expand the 4G-based Voice over Long-Term Evolution (VoLTE) services ...

Olympus to support endoscopic AI diagnosis education for doctors in Thailand

Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) took part in a ...

Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1 Incheon, South Korea--(Antara/Business ...